AURKA-IN-1

CAT:

804-HY-161407

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: AURKA-IN-1 (compound 9) is an cell-active covalent AURKA inhibitor. AURKA-IN-1 is a lysine-reactive activity probe[1].
Target Antigen: Aurora Kinase
Type: Reference compound
Related Pathways: Cell Cycle/DNA Damage;Epigenetics
Applications: Cancer-Kinase/protease
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/aurka-in-1.html
Solubility: 10 mM in DMSO
Smiles: O=C(NCC#C)C1=CC(NC2=NNC(C3CC3)=C2)=NC(N4CCN(C(C5=CC=C(OS(=O)(F)=O)C=C5)=O)CC4)=N1
Molecular Weight: 568.58
References & Citations: [1]Guanghui Tang, et al. Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development. Angew Chem Int Ed Engl. 2024, 63, 12.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-161407	AURKA-IN-1
HY-158038	AurkA allosteric-IN-1
HY-155464	VEGFR-2/AURKA-IN-1
HY-162837	AURKA against 1
HY-P702672	AURKA, Human (sf9, GST)
HY-RS01268	Aurka Rat Pre-designed siRNA Set A
HY-RS01266	AURKA Human Pre-designed siRNA Set A
HY-RS01267	Aurka Mouse Pre-designed siRNA Set A
HY-163546	HSV-1-IN-1
HY-144666-02	GLS-1-IN-1